Related references
Note: Only part of the references are listed.Keap1 deletion accelerates mutant K-ras/p53-driven cholangiocarcinoma
Tatsuhide Nabeshima et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2020)
Undermining Glutaminolysis Bolsters Chemotherapy While NRF2 Promotes Chemoresistance in KRAS-Driven Pancreatic Cancers
Suman Mukhopadhyay et al.
CANCER RESEARCH (2020)
An evaluation of dimethyl fumarate for the treatment of relapsing remitting multiple sclerosis
Cristina Valencia-Sanchez et al.
EXPERT OPINION ON PHARMACOTHERAPY (2020)
5-Fluorouracil Enhances the Antitumor Activity of the Glutaminase Inhibitor CB-839 against PIK3CA-Mutant Colorectal Cancers
Yiqing Zhao et al.
CANCER RESEARCH (2020)
LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in KRAS-Mutant Lung Adenocarcinoma
Ana Galan-Cobo et al.
CANCER RESEARCH (2019)
Simultaneous K-ras activation and Keap1 deletion cause atrophy of pancreatic parenchyma
Shin Hamada et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2018)
ClinicalandPathological Characteristics of KEAP1- and NFE2L2-Mutated Non-Small Cell Lung Carcinoma (NSCLC)
Rieke Frank et al.
CLINICAL CANCER RESEARCH (2018)
Simultaneous Inhibition of MEK and Hh Signaling Reduces Pancreatic Cancer Metastasis
Dongsheng Gu et al.
CANCERS (2018)
Halofuginone enhances the chemo-sensitivity of cancer cells by suppressing NRF2 accumulation
Kouhei Tsuchida et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Stress-sensing mechanisms and the physiological roles of the Keap1-Nrf2 system during cellular stress
Takafumi Suzuki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis
Rodrigo Romero et al.
NATURE MEDICINE (2017)
Nrf2 promotes mutant K-ras/p53-driven pancreatic carcinogenesis
Shin Hamada et al.
CARCINOGENESIS (2017)
Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer
Amira Elgogary et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Identification of pyrazolopyridazinones as PDEd inhibitors
Bjoern Papke et al.
NATURE COMMUNICATIONS (2016)
p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming
Tetsuya Saito et al.
NATURE COMMUNICATIONS (2016)
Pancreatic cancer biology and genetics from an evolutionary perspective
Alvin Makohon-Moore et al.
NATURE REVIEWS CANCER (2016)
Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer
Matt I. Gross et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Pilot study evaluating broccoli sprouts in advanced pancreatic cancer (POUDER trial) - study protocol for a randomized controlled trial
Vladimir J. Lozanovski et al.
TRIALS (2014)
PrimerBank: a PCR primer database for quantitative gene expression analysis, 2012 update
Xiaowei Wang et al.
NUCLEIC ACIDS RESEARCH (2012)
Sensitization of Human Pancreatic Cancer Cells Harboring Mutated K-ras to Apoptosis
Ling Shen et al.
PLOS ONE (2012)
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
Gina M. De Nicola et al.
NATURE (2011)
NRF2 Mutation Confers Malignant Potential and Resistance to Chemoradiation Therapy in Advanced Esophageal Squamous Cancer
Tatsuhiro Shibata et al.
NEOPLASIA (2011)
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial
Ronald P. DeMatteo et al.
LANCET (2009)
Nrf2 regulates the alternative first exons of CD36 in macrophages through specific antioxidant response elements
Atsushi Maruyama et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2008)
Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer
Tatsuhiro Shibata et al.
GASTROENTEROLOGY (2008)
Subcellular localization and cytoplasmic complex status of endogenous Keap1
Yoriko Watai et al.
GENES TO CELLS (2007)
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
Manabu Soda et al.
NATURE (2007)
Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity
H Okawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Trp53R172H and KraSG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
SR Hingorani et al.
CANCER CELL (2005)
Share Paper
